Jose L. Lopez-Ribot Department of Biology University of Texas at San Antonio Biography Publications Institution JoVE Articles Jose L. Lopez-Ribot has not added a biography. If you are Jose L. Lopez-Ribot and would like to personalize this page please email our Author Liaison for assistance. Publications Addition of DNase Improves the in Vitro Activity of Antifungal Drugs Against Candida Albicans Biofilms Mycoses. Jan, 2012 | Pubmed ID: 21668524 Sodium Hypochlorite, Chlorhexidine Gluconate, and Commercial Denture Cleansers As Disinfecting Agents Against Candida Albicans: An in Vitro Comparison Study General Dentistry. Nov, 2011 | Pubmed ID: 22313927 Effect of Exogenous Administration of Candida Albicans Autoregulatory Alcohols in a Murine Model of Hematogenously Disseminated Candidiasis Journal of Basic Microbiology. Nov, 2011 | Pubmed ID: 22052380 Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms PLoS Pathogens. Sep, 2011 | Pubmed ID: 21931556 Validation of the Tetracycline Regulatable Gene Expression System for the Study of the Pathogenesis of Infectious Disease PloS One. 2011 | Pubmed ID: 21633704 Effects of Fluconazole, Amphotericin B, and Caspofungin on Candida Albicans Biofilms Under Conditions of Flow and on Biofilm Dispersion Antimicrobial Agents and Chemotherapy. Jul, 2011 | Pubmed ID: 21518839 An Easy and Economical in Vitro Method for the Formation of Candida Albicans Biofilms Under Continuous Conditions of Flow Virulence. Nov-Dec, 2010 | Pubmed ID: 21178492 The Transcriptional Regulator Nrg1p Controls Candida Albicans Biofilm Formation and Dispersion Eukaryotic Cell. Oct, 2010 | Pubmed ID: 20709787 Dispersion As an Important Step in the Candida Albicans Biofilm Developmental Cycle PLoS Pathogens. Mar, 2010 | Pubmed ID: 20360962 Presence of Extracellular DNA in the Candida Albicans Biofilm Matrix and Its Contribution to Biofilms Mycopathologia. May, 2010 | Pubmed ID: 20012895 Characteristics of Candida Albicans Biofilms Grown in a Synthetic Urine Medium Journal of Clinical Microbiology. Dec, 2009 | Pubmed ID: 19794044 Treatment and Prevention of Candida Albicans Biofilms with Caspofungin in a Novel Central Venous Catheter Murine Model of Candidiasis The Journal of Antimicrobial Chemotherapy. Sep, 2009 | Pubmed ID: 19584104 Adhesion of Candida Albicans to Endothelial Cells Under Physiological Conditions of Flow Infection and Immunity. Sep, 2009 | Pubmed ID: 19581400 Design of a Simple Model of Candida Albicans Biofilms Formed Under Conditions of Flow: Development, Architecture, and Drug Resistance Mycopathologia. Sep, 2009 | Pubmed ID: 19370400 Efficacy of a Genetically Engineered Candida Albicans Tet-NRG1 Strain As an Experimental Live Attenuated Vaccine Against Hematogenously Disseminated Candidiasis Clinical and Vaccine Immunology : CVI. Mar, 2009 | Pubmed ID: 19144791 Expression Levels of a Filament-specific Transcriptional Regulator Are Sufficient to Determine Candida Albicans Morphology and Virulence Proceedings of the National Academy of Sciences of the United States of America. Jan, 2009 | Pubmed ID: 19116272 Effect of Tunicamycin on Candida Albicans Biofilm Formation and Maintenance The Journal of Antimicrobial Chemotherapy. Mar, 2009 | Pubmed ID: 19098294 A Simple and Reproducible 96-well Plate-based Method for the Formation of Fungal Biofilms and Its Application to Antifungal Susceptibility Testing Nature Protocols. 2008 | Pubmed ID: 18772877 Candida Albicans-endothelial Cell Interactions: a Key Step in the Pathogenesis of Systemic Candidiasis Infection and Immunity. Oct, 2008 | Pubmed ID: 18573891 A Seed and Feed Model for the Formation of Candida Albicans Biofilms Under Flow Conditions Using an Improved Modified Robbins Device Revista Iberoamericana De MicologÃa : órgano De La Asociación Española De Especialistas En MicologÃa. Mar, 2008 | Pubmed ID: 18338926 UME6, a Novel Filament-specific Regulator of Candida Albicans Hyphal Extension and Virulence Molecular Biology of the Cell. Apr, 2008 | Pubmed ID: 18216277 Use of a Genetically Engineered Strain to Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms During Candida Albicans Systemic Infection in Immunodeficient Mice Infection and Immunity. Jan, 2008 | Pubmed ID: 17967861 Inhibition on Candida Albicans Biofilm Formation Using Divalent Cation Chelators (EDTA) Mycopathologia. Dec, 2007 | Pubmed ID: 17909983 Proteomics to Study Candida Albicans Biology and Pathogenicity Infectious Disorders Drug Targets. Dec, 2006 | Pubmed ID: 17168799 A Proteomic-based Approach for the Identification of Candida Albicans Protein Components Present in a Subunit Vaccine That Protects Against Disseminated Candidiasis Proteomics. Nov, 2006 | Pubmed ID: 17051645 Biofilm Formation by Candida Albicans Mutants for Genes Coding Fungal Proteins Exhibiting the Eight-cysteine-containing CFEM Domain FEMS Yeast Research. Nov, 2006 | Pubmed ID: 17042757 Inhibition of Filamentation Can Be Used to Treat Disseminated Candidiasis Antimicrobial Agents and Chemotherapy. Oct, 2006 | Pubmed ID: 17005810 Proteomics for the Analysis of the Candida Albicans Biofilm Lifestyle Proteomics. Nov, 2006 | Pubmed ID: 17001605 Drosophila Melanogaster As a Facile Model for Large-scale Studies of Virulence Mechanisms and Antifungal Drug Efficacy in Candida Species The Journal of Infectious Diseases. Apr, 2006 | Pubmed ID: 16518764 A Role for Efg1p in Candida Albicans Interactions with Extracellular Matrices FEMS Microbiology Letters. Mar, 2006 | Pubmed ID: 16487333 Use of Genome Information for the Study of the Pathogenesis of Fungal Infections and the Development of Diagnostic Tools Revista Iberoamericana De MicologÃa : órgano De La Asociación Española De Especialistas En MicologÃa. Dec, 2005 | Pubmed ID: 16499417 Candida Albicans Biofilms: More Than Filamentation Current Biology : CB. Jun, 2005 | Pubmed ID: 15964263 Candida Biofilms: an Update Eukaryotic Cell. Apr, 2005 | Pubmed ID: 15821123 Denture Stomatitis: a Role for Candida Biofilms Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. Jul, 2004 | Pubmed ID: 15243471 Antibody Response to Candida Albicans Cell Wall Antigens FEMS Immunology and Medical Microbiology. Jul, 2004 | Pubmed ID: 15196567 Inducible Defense Mechanism Against Nitric Oxide in Candida Albicans Eukaryotic Cell. Jun, 2004 | Pubmed ID: 15189992 Caspofungin Resistance in Candida Albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis Antimicrobial Agents and Chemotherapy. Apr, 2004 | Pubmed ID: 15047549 The C-terminal Antibody Binding Domain of Candida Albicans Mp58 Represents a Protective Epitope During Candidiasis FEMS Microbiology Letters. Mar, 2004 | Pubmed ID: 15033231 Changes in Susceptibility to Posaconazole in Clinical Isolates of Candida Albicans The Journal of Antimicrobial Chemotherapy. Jan, 2004 | Pubmed ID: 14657086 Antifungal Combinations Against Candida Albicans Biofilms in Vitro Antimicrobial Agents and Chemotherapy. Nov, 2003 | Pubmed ID: 14576141 Engineered Control of Cell Morphology in Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida Albicans During Infection Eukaryotic Cell. Oct, 2003 | Pubmed ID: 14555488 Inhibition of Candida Albicans Biofilm Formation by Farnesol, a Quorum-sensing Molecule Applied and Environmental Microbiology. Nov, 2002 | Pubmed ID: 12406738 In Vitro Pharmacodynamic Properties of Three Antifungal Agents Against Preformed Candida Albicans Biofilms Determined by Time-kill Studies Antimicrobial Agents and Chemotherapy. Nov, 2002 | Pubmed ID: 12384379 In Vitro Activity of Caspofungin Against Candida Albicans Biofilms Antimicrobial Agents and Chemotherapy. Nov, 2002 | Pubmed ID: 12384370 The Filamentation Pathway Controlled by the Efg1 Regulator Protein is Required for Normal Biofilm Formation and Development in Candida Albicans FEMS Microbiology Letters. Aug, 2002 | Pubmed ID: 12204378 Replacement of Candida Albicans with C. Dubliniensis in Human Immunodeficiency Virus-infected Patients with Oropharyngeal Candidiasis Treated with Fluconazole Journal of Clinical Microbiology. Sep, 2002 | Pubmed ID: 12202543 Investigation of Multidrug Efflux Pumps in Relation to Fluconazole Resistance in Candida Albicans Biofilms The Journal of Antimicrobial Chemotherapy. Jun, 2002 | Pubmed ID: 12039889 In Vitro Activity of Caspofungin (MK-0991) Against Candida Albicans Clinical Isolates Displaying Different Mechanisms of Azole Resistance Journal of Clinical Microbiology. Jun, 2002 | Pubmed ID: 12037093 Molecular Mechanisms of Fluconazole Resistance in Candida Dubliniensis Isolates from Human Immunodeficiency Virus-infected Patients with Oropharyngeal Candidiasis Antimicrobial Agents and Chemotherapy. Jun, 2002 | Pubmed ID: 12019078 קנדידה אלביקנס biofilm צ'יפ (ע"א BChip) להקרנה תפוקה גבוהה תרופות נגד פטריות Anand Srinivasan1, Jose L. Lopez-Ribot2, Anand K. Ramasubramanian1 1Department of Biomedical Engineering, University of Texas at San Antonio, 2Department of Biology, University of Texas at San Antonio JoVE 3845 Bioingegneria 96 microtiter ובכן פלייט מבוססי שיטה ליצירת ניטור ובדיקה של רגישות נגד פטריות קנדידה אלביקנס Biofilms Christopher G. Pierce1,2, Priya Uppuluri1,2, Sushma Tummala1,2, Jose L. Lopez-Ribot1,2 1Department of Biology, University of Texas San Antonio - UTSA, 2South Texas Center for Emerging Infectious Diseases, University of Texas San Antonio - UTSA JoVE 2287 Immunologia e infezioni
קנדידה אלביקנס biofilm צ'יפ (ע"א BChip) להקרנה תפוקה גבוהה תרופות נגד פטריות Anand Srinivasan1, Jose L. Lopez-Ribot2, Anand K. Ramasubramanian1 1Department of Biomedical Engineering, University of Texas at San Antonio, 2Department of Biology, University of Texas at San Antonio JoVE 3845 Bioingegneria
96 microtiter ובכן פלייט מבוססי שיטה ליצירת ניטור ובדיקה של רגישות נגד פטריות קנדידה אלביקנס Biofilms Christopher G. Pierce1,2, Priya Uppuluri1,2, Sushma Tummala1,2, Jose L. Lopez-Ribot1,2 1Department of Biology, University of Texas San Antonio - UTSA, 2South Texas Center for Emerging Infectious Diseases, University of Texas San Antonio - UTSA JoVE 2287 Immunologia e infezioni